Cargando…
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
Clinically used botulinum neurotoxins (BoNTs) are natural products of Clostridium botulinum. A novel, recombinant BoNT type A1 (rBoNT/A1; IPN10260) has been synthesized using the native amino acid sequence expressed in Escherichia coli and has previously been characterized in vitro and ex vivo. Here...
Autores principales: | Périer, Cindy, Martin, Vincent, Cornet, Sylvie, Favre‐Guilmard, Christine, Rocher, Marie‐Noelle, Bindler, Julien, Wagner, Stéphanie, Andriambeloson, Emile, Rudkin, Brian, Marty, Rudy, Vignaud, Alban, Beard, Matthew, Lezmi, Stephane, Kalinichev, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502944/ https://www.ncbi.nlm.nih.gov/pubmed/34632725 http://dx.doi.org/10.1002/prp2.857 |
Ejemplares similares
-
The use of the dynamic weight bearing test to assess the effects of acute, intramuscularly administered botulinum neurotoxin type A1 in rats
por: Cornet, Sylvie, et al.
Publicado: (2020) -
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo
por: Donald, Sarah, et al.
Publicado: (2018) -
Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus
por: Cornet, Sylvie, et al.
Publicado: (2020) -
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
por: Elliott, Mark, et al.
Publicado: (2019) -
Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice
por: Oehler, Beatrice, et al.
Publicado: (2022)